Assemblies of Alzheimer's peptides Aβ25-35 and Aβ31-35: Reverse-turn conformation and side-chain interactions revealed by X-ray diffraction

Journal of Structural Biology

Volumn 141, Issue 2, 2003, Pages 156-170

  Bond, Jeremy P ^a,d   Deverin, Sean P ^a   Inouye, Hideyo ^a   El Agnaf, Omar M A ^b   Teeter, Martha M ^a,c   Kirschner, Daniel A ^a  

^a BOSTON COLLEGE   (United States)

^b LANCASTER UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Global Prior Art Inc   (United States)

Author keywords

Alzheimer's disease; Amyloid; Antagonist; G protein coupled receptor; Neurotoxicity; Reverse turn; Substance P; Tachykinin; X ray diffraction

Indexed keywords

AMYLOID BETA PROTEIN; G PROTEIN COUPLED RECEPTOR; GLYCINE; ISOLEUCINE; LEUCINE; METHIONINE; OLIGOMER; PHENYLALANINE; TACHYKININ;

ALZHEIMER DISEASE; ARTICLE; BINDING SITE; CYTOTOXICITY; ELECTRON; ELECTRON MICROSCOPY; HYDROGEN BOND; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; X RAY DIFFRACTION;

EID: 0037291289     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-8477(02)00625-1     Document Type: Article

References (85)

1. Abu Shanab A.A., Allen J.M., Guthrie D.J., Irvine G.B., Murphy R.F., Walker B. Effects of some neurokinin A analogues on tachykinin-induced contraction of guinea pig trachea. Peptides. 12:1991;1069-1075.
2. Arispe N., Rojas B., Pollard H.B. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA. 90:1993;567-571.
3. Arispe N., Pollard H.B., Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [Aβ-P-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA. 90:1993;10573-10577.
4. Aubry A., Birlirakis N., Sakarellos-Daitsiotis M., Sakarellos C., Marraud M. A crystal molecular conformation of leucine-enkephalin related to the morphine molecule. Biopolymers. 28:1989;27-40.
5. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
6. Blundell T.L., Hearn L., Tickle I.J., Palmer R.A., Morgan B.A., Smith G.D., Griffin J.F. Crystal structure of [Leu5]enkephalin. Science. 205:1979;220.
7. Boland K., Manias K., Perlmutter D.H. Specificity in recognition of amyloid-β peptide by the serpin-enzyme complex receptor in hepatoma cells and neuronal cells. J. Biol. Chem. 270:1995;28022-28028.
8. Booth D.R., Sunde M., Bellotti V., Robinson C.V., Hutchinson W.L., Fraser P.E., Hawkins P.N., Dobson C.M., Radford S.E., Blake C.C., Pepys M.B. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature. 385:1997;787-793.
9. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 4:1983;187-217.
10. Busciglio J., Lorenzo A., Yeh J., Yankner B.A. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:1995;879-888.
11. Cella R.J., Lee B., Hughes R.E. Lorentz and orientation factors in fiber X-ray diffraction analysis. Acta Crystallogr. Sect. A. 26:1970;118-124.
12. Cheung N.S., Small D.H., Livett B.G. An amyloid peptide, β A4 25-35, mimics the function of substance P on modulation of nicotine-evoked secretion and desensitization in cultured bovine adrenal chromaffin cells. J. Neurochem. 60:1993;1163-1166.
13. Coles M., Bicknell W., Watson A.A., Fairlie D.P., Craik D.J. Solution structure of amyloid β-peptide (1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry. 37:1998;11064-11077.
14. Di Stefano M., Aleppo G., Casabona G., Genazzani A.A., Scapagnini U., Nicoletti F. Amyloid β protein does not interact with tachykinin receptors coupled to inositol phospholipid hydrolysis in human astrocytoma cells. Brain Res. 600:1993;166-168.
15. Eanes E.D., Glenner G.G. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16:1968;673-677.
16. Eaton W.A., Munoz V., Hagen S.J., Jas G.S., Lapidus L.J., Henry E.R., Hofrichter J. Fast kinetics and mechanisms in protein folding. Annu. Rev. Biophys. Biomol. Struct. 29:2000;327-359.
17. El-Agnaf O.M.A., Harriott P., Guthrie D.J.S., Irvine G.B., Walker B. The synthesis of some peptides related to the amyloid β-peptide 25-35: Use of N-(2-hydroxy-4-methoxybenzyl) protection. Lett. Peptide Sci. 1:1994;135-141.
18. Enya M., Morishima-Kawashima M., Yoshimura M., Shinkai Y., Kusui K., Khan K., Games D., Schenk D., Sugihara S., Yamaguchi H., Ihara Y. Appearance of sodium dodecyl sulfate-stable amyloid β-protein (Aβ) dimer in the cortex during aging. Am. J. Pathol. 154:1999;271-279.
19. Fraser R.D.B., MacRae T.P. An investigation of the structure of β-keratin. J. Mol. Biol. 5:1962;457-466.
20. Fraser P.E., Duffy L.K., O'Malley M.B., Nguyen J., Inouye H., Kirschner D.A. Morphology and antibody recognition of synthetic Aβ-amyloid peptides. J. Neurosci. Res. 28:1991;474-485.
21. Fraser P.E., Nguyen J.T., Surewicz W.K., Kirschner D.A. pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys. J. 60:1991;1190-1201.
22. Frishman D., Argos P. Knowledge-based protein secondary structure assignment. Proteins. 23:1995;566-579.
23. Garzon-Rodriguez W., Sepulveda-Becerra M., Milton S., Glabe C.G. Soluble amyloid Aβ(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272:1997;21037-21044.
24. Giannotti D., Perrotta E., Di Bugno C., Nannicini R., Harmat J.J.S., Giolitti A., Patacchini R., Renzetti A.R., Rotondaro L., Giuliani S., Altamura M., Maggi C.A. Discovery of potent cyclic pseudopeptide human tachykinin NK-2 receptor antagonists. J. Med. Chem. 43:2000;4041-4044.
25. Glenner G.G., Wong C.W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
26. Glucksman M.J., Hay R.D., Makowski L. X-ray diffraction from magnetically oriented solutions of macromolecular assemblies. Science. 231:1986;1273-1276.
27. Griffin J.F., Langs D.A., Smith G.D., Blundell T.L., Tickle I.J., Bedarkar S. The crystal structures of [Met5]enkephalin and a third form of [Leu5]enkephalin: Observations of a novel pleated beta-sheet. Proc. Natl. Acad. Sci. USA. 83:1986;3272-3276.
28. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis. 18:1997;2714-2723.
29. Guex N., Diemand A., Peitsch M.C. Protein modelling for all. Trends Biochem. Sci. 24:1999;364-367.
30. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., Selkoe D.J. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
31. Howlett D.R., Jennings K.H., Lee D.C., Clark M.S., Brown F., Wetzel R., Wood S.J., Camilleri P., Roberts G.W. Aggregation state and neurotoxic properties of Alzheimer β-amyloid peptide. Neurodegeneration. 4:1995;23-32.
32. Humphrey W., Dalke A., Schulten K. VMD - visual molecular dynamics. J. Mol. Graph. 14:1996;33-38.
33. Inouye H., Fraser P.E., Kirschner D.A. Structure of β-crystallite assemblies formed by Alzheimer β-amyloid protein analogues: Analysis by X-ray diffraction. Biophys. J. 64:1993;502-519.
34. Inouye H., Domingues F.S., Damas A.M., Saraiva M.J., Lundgren E., Sandgren O., Kirschner D.A. Analysis of X-ray diffraction patterns from amyloid of biopsied vitreous humor and kidney of transthyretin (TTR) Met30 familial amyloidotic polyneuropathy (FAP) patients: Axially arrayed TTR monomers constitute the protofilament. Amyloid: Int. J. Exp. Clin. Invest. 5:1998;163-174.
35. Inouye H., Bond J., Baldwin M.A., Ball H.L., Prusiner S.B., Kirschner D.A. Structural changes in a hydrophobic domain of the prion protein induced by hydration and by ala. → Val and Pro → Leu substitutions J. Mol. Biol. 300:2000;1283-1296.
36. Inouye H., Kirschner D.A. X-ray diffraction analysis of scrapie prion: Intermediate and folded structures in a peptide containing two putative α-helices. J. Mol. Biol. 268:1997;375-389.
37. Jones S., Thornton J.M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA. 93:1996;13-20.
38. Joslin G., Fallon R.J., Bullock J., Adams S.P., Perlmutter D.H. The SEC receptor recognizes a pentapeptide neodomain of α1-antitrypsin-protease complexes. J. Biol. Chem. 266:1991;11282-11288.
39. Joslin G., Krause J.E., Hershey A.D., Adams S.P., Fallon R.J., Perlmutter D.H. Amyloid-β peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor. J. Biol. Chem. 266:1991;21897-21902.
40. Kabsch W., Sander C. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:1983;2577-2637.
41. Kirschner D.A., Inouye H., Duffy L.K., Sinclair A., Lind M., Selkoe D.J. Synthetic peptide homologous to β-protein of Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA. 84:1987;6953-6957.
42. Kirschner D.A., Elliott-Bryant R., Szumowski K.E., Gonnerman W.A., Kindy M.S., Sipe J.D., Cathcart E.S. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice. J. Struct. Biol. 124:1998;88-98.
43. Kowall N.W., Beal M.F., Busciglio J., Duffy L.K., Yankner B.A. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA. 88:1991;7247-7251.
44. Kraulis P.J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.
45. Laczko I., Holly S., Konya Z., Soos K., Varga J.L., Hollosi M., Penke B. Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 region. Biochem. Biophys. Res. Commun. 205:1994;120-126.
46. 2 Arch. Biochem. Biophys. 335:1996;381-387.
47. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26:1993;283-291.
48. Laws D.D., Bitter H.M., Liu K., Ball H.L., Kaneko K., Wille H., Cohen F.E., Prusiner S.B., Pines A., Wemmer D.E. Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration. Proc. Natl. Acad. Sci. USA. 98:2001;11686-11690.
49. Lee J.P., Stimson E.R., Ghilardi J.R., Mantyh P.W., Lu Y.A., Felix A.M., Llanos W., Behbin A., Cummings M., Van Criekinge M., Timms W., Maggio J.E. 1H NMR of Aβ amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence. Biochemistry. 34:1995;5191-5200.
50. Lockhart B.P., Benicourt C., Junien J.L., Privat A. Inhibitors of free radical formation fail to attenuate direct β-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39:1994;494-505.
51. Lorenzo A., Yuan M., Zhang Z., Paganetti P.A., Sturchler-Pierrat C., Staufenbiel M., Mautino J., Vigo F.S., Sommer B., Yankner B.A. Amyloid β interacts with the amyloid precursor protein: A potential toxic mechanism in Alzheimer's disease. Nature Neurosci. 3:2000;460-464.
52. Lorenzo A., Yankner B.A. β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA. 91:1994;12243-12247.
53. Ma B., Nussinov R. Molecular dynamics simulations of a β-hairpin fragment of protein G: Balance between side-chain and backbone forces. J. Mol. Biol. 296:2000;1091-1104.
54. Mason R.P., Estermyer J.D., Kelly J.F., Mason P.E. Alzheimer's disease amyloid β peptide 25-35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis. Biochem. Biophys. Res. Commun. 222:1996;78-82.
55. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
56. Matthews B.M. Solvent content of protein crystals. J. Mol. Biol. 33:1968;491-497.
57. Mattson M.P., Rydel R.E. β-Amyloid precursor protein and Alzheimer's disease: The peptide plot thickens. Neurobiol. Aging. 13:1992;617-621.
58. McCallister E.L., Alm E., Baker D. Critical role of β-hairpin formation in protein G folding. Nature Struct. Biol. 7:2000;669-673.
59. McRee D.E. "XtalView/Xfit" - a versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125:1999;156-165.
60. Mitsuhashi M., Akitaya T., Turk C.W., Payan D.G. Amyloid β protein substituent peptides do not interact with the substance P receptor expressed in cultured cells. Brain Res. Mol. Brain Res. 11:1991;177-180.
61. Munoz V., Henry E.R., Hofrichter J., Eaton W.A. A statistical mechanical model for β-hairpin kinetics. Proc. Natl. Acad. Sci. USA. 95:1998;5872-5879.
62. Munoz V., Thompson P.A., Hofrichter J., Eaton W.A. Folding dynamics and mechanism of β-hairpin formation. Nature. 390:1997;196-199.
63. Nguyen J.T., Inouye H., Baldwin M.A., Fletterick R.J., Cohen F.E., Prusiner S.B., Kirschner D.A. X-ray diffraction of scrapie prion rods and PrP peptides. J. Mol. Biol. 252:1995;412-422.
64. Oldenbourgh R., Phillips W.C. Small permanent magnet for fields up to2.6T. Rev. Sci. Instrum. 57:1986;2362-2365.
65. Perczel A., Foxman B.M., Fasman G.D. How reverse turns may mediate the formation of helical segments in proteins: An X-ray model. Proc. Natl. Acad. Sci. USA. 89:1992;8210-8214.
66. Pernow B. Substance P. Pharmacol. Rev. 35:1983;85-141.
67. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
68. Rymer D.L., Good T.A. The role of G protein activation in the toxicity of amyloidogenic Aβ-(-1-40), Aβ-(25-35), and bovine calcitonin. J. Biol. Chem. 276:2001;2523-2530.
69. Rovero P., Quartara L., Astolfi M., Patacchini R., Giachetti A., Maggi C.A. Structure-activity study of the C-terminal residue of MEN 10207 tachykinin antagonist. Peptides. 13:1992;207-208.
70. Sayle R.A., Milner-White E.J. RasMol: Biomolecular graphics for all. Trends Biochem. Sci. 20:1995;374.
71. Schaefer M., Bartels C., Karplus M. Solution conformations and thermodynamics of structured peptides: Molecular dynamics simulation with an implicit solvation model. J. Mol. Biol. 284:1998;835-848.
72. Sebastiao M.P., Lamzin V., Saraiva M.J., Damas A.M. Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution. J. Mol. Biol. 306:2001;733-744.
73. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:1999;A23-A31.
74. Sheldrick G.M., Schneider T.R. SHELXL: High-resolution refinement. Methods Enzymol. 277:1997;319-343.
75. Sipe J.D., Cohen A.S. Review history of the amyloid fibril. J. Struct. Biol. 130:2000;88-98.
76. Sorimachi K., Craik D.J., Lloyd E.J., Beyreuther K., Masters C.L. Identification of a β-turn in the tertiary structure of a peptide fragment of the Alzheimer amyloid protein. Biochem. Int. 22:1990;447-454.
77. Sticht H., Bayer P., Willbold D., Dames S., Hilbich C., Beyreuther K., Frank R.W., Rosch P. Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur. J. Biochem. 233:1995;293-298.
78. Sundaralingam M., Sekharudu Y.C. Water-inserted α-helical segments implicate reverse turns as folding intermediates. Science. 244:1989;1333-1337.
79. Talafous J., Marcinowski K.J., Klopman G., Zagorski M.G. Solution structure of residues 1-28 of the amyloid β-peptide. Biochemistry. 33:1994;7788-7796.
80. Terzi E., Holzemann G., Seelig J. Alzheimer β-amyloid peptide 25-35: Electrostatic interactions with phospholipid membranes. Biochemistry. 33:1994;7434-7441.
81. Vriend G. WHAT IF: A molecular modeling and drug design program. J. Mol. Graph. 8:1990;52-56.
82. Whitehead T.L., McNair S.D., Hadden C.E., Young J.K., Hicks R.P. Membrane induced secondary structures of neuropeptides: A comparison of the solution conformations adopted by agonists and antagonists of the mammalian tachykinin NK1 receptor. J. Med. Chem. 41:1998;1497-1506.
83. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
84. Zhang C., Lambert M.P., Bunch C., Barber K., Wade W.S., Krafft G.A., Klein W.L. Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's Aβ peptide. J. Biol. Chem. 269:1994;25247-25250.
85. Zhang S., Iwata K., Lachenmann M.J., Peng J.W., Li S., Stimson E.R., Lu Y., Felix A.M., Maggio J.E., Lee J.P. The Alzheimer's peptide Aβ adopts a collapsed coil structure in water. J. Struct. Biol. 130:2000;130-141.